Health & Medicine

6
facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194December 18, 2014

Penn and UGA Awarded $23.4 Million Contract for Pathogen Genomics Database

blurb: 
A five-year, $23.4 million contract from the NIH will support a growing database of genomic information about disease-causing microbes, co-directed by the University of Pennsylvania's David Roos.

At the turn of the millennium, the cost to sequence a single human genome exceeded $50 million, and the process took a decade to complete. Microbes have genomes, too, and the first reference genome for a malaria parasite was completed in 2002 at a cost of roughly $15 million. But today researchers can sequence a genome in a single afternoon for just a few thousand dollars.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658December 11, 2014

Penn Researchers Tame the Inflammatory Response in Kidney Dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States.

facebook twitter google print email
Media Contact:Greg Richter | gregory.richter@uphs.upenn.edu | 215-614-1937December 12, 2014

Penn Medicine Study: U.S. Workers Sacrifice Sleep for Work Hours and Long Commutes

An increasing number of studies show that chronically restricted sleep to less than seven hours per day impairs performance, increases the risk for errors and accidents, and is associated with negative health consequences like obesity, diabetes, and cardiovascular disease.

Penn Researcher to Study Impact of Changing Nursing Practices on Patient Health

December 12, 2014

Linda Aiken of the School of Nursing is highlighted for studying nursing practices.

Long Radiation Treatments Called Unnecessary in Many Breast Cancer Cases

December 10, 2014

New research about breast cancer treatment from the Perelman School of Medicine’s Justin Bekelman and Ezekiel Emanuel, also of the Whar

Article Source: New York Times
facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653December 10, 2014

Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation

Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicineresearchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660December 10, 2014

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

blurb: 
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659December 8, 2014

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

blurb: 
Findings Include Response Rates Over 90 Percent in Pediatric Acute Lymphoblastic Leukemia, and First Results of Non-Hodgkin Lymphoma Trial

The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194December 8, 2014

Penn Vet-Berkeley Study: New Therapy Holds Promise for Restoring Vision

A new chemical-genetic therapy restores light responses to the retinas of blind mice and dogs and enables the mice to guide their behavior according to visual cues, setting the stage for clinical trial in humans.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194December 8, 2014

The Women in Science Program at Penn Offers Cross-generational Wisdom

blurb: 
Ware College House’s Women in Science program, founded by Medicine’s Helen Davies, offers support and inspiration for budding scientists, both female and male.

By Madeleine Stone  @themadstone